| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2010 ( Subtotal = -$391,672 ) |
| | 2010 | 2009 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVE | LOUISVILLE | KY | 40204-1544 | JEFFERSON | USA | R42EY017518 | TARGETING DRUG DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 000 | 3 | NIH | 4/19/2010 | -$391,672 |
|
| Issue Date FY: 2009 ( Subtotal = $689,667 ) |
| | 2009 | 2009 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVE | LOUISVILLE | KY | 40204-1544 | JEFFERSON | USA | R42EY017518 | TARGETING DRUG DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 000 | 3 | NIH | 7/10/2009 | $689,667 |
|
| Issue Date FY: 2008 ( Subtotal = $287,662 ) |
| | 2008 | 2008 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R42EY017518 | TARGETING DRUG DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 000 | 2 | NIH | 9/8/2008 | $287,662 |
|
| Issue Date FY: 2006 ( Subtotal = $635,758 ) |
| | 2006 | 2006 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R41EY017473 | PREVENTING CHOROIDAL NEOVASCULARIZATION BY LONG-TERM TRANSSCLERAL DRUG DELIVERY | 000 | 1 | NIH | 5/1/2006 | $293,017 |
| | 2006 | 2006 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R41EY017518 | TARGETING DRUG-DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 000 | 1 | NIH | 6/19/2006 | $342,741 |
|
| Issue Date FY: 2005 ( Subtotal = $252,000 ) |
| | 2005 | 2005 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R43GM070193 | BYPASSING FLUIDICS IN PROTEOMIC SCREENING | 000 | 2 | NIH | 6/2/2005 | $252,000 |
|
| Issue Date FY: 2004 ( Subtotal = $504,798 ) |
| | 2004 | 2004 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R43GM071252 | MODIFIED BACTERIAL SYSTEM FOR VIVO DIRECTION EVOLUTION | 000 | 1 | NIH | 3/29/2004 | $252,798 |
| | 2004 | 2004 | POTENTIA PHARMACEUTICALS | 1434 GODDARD AVENUE | LOUISVILLE | KY | 40204 | JEFFERSON | USA | R43GM070193 | BYPASSING FLUIDICS IN PROTEOMIC SCREENING | 000 | 1 | NIH | 2/3/2004 | $252,000 |
|
|
